Nexavar plus standard chemotherapy improves progression-free survival of patients with breast cancer May 24, 2011
Viralytics receives FDA reply regarding clinical hold on phase II Cavatek trial in melanoma May 23, 2011
PharmaGap's anticancer candidate GAP-107B8 shows improved potency and bioavailability in liposomes May 23, 2011
RSS